Roche Digital LightCycler System

Roche has launched the Digital LightCycler System, which can divide DNA and RNA from an already extracted clinical sample into as many as 100,000 microscopic individual reactions on which PCR is then performed. The system is designed for laboratories performing highly sensitive and precise DNA and RNA analysis in areas such as oncology and infectious diseases. Applications include the detection of ultra-rare targets, accurately quantifying how much target DNA or RNA is present at a molecular level, and other high-precision analysis, Roche said. The system will be available in 15 countries worldwide in 2022 with plans to launch into more countries in the near future. It will also be CE-marked and has 510(k) exempt status from the US Food and Drug Administration, Roche noted.